These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 12917690)

  • 1. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB.
    Brummelkamp TR; Nijman SM; Dirac AM; Bernards R
    Nature; 2003 Aug; 424(6950):797-801. PubMed ID: 12917690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.
    Kovalenko A; Chable-Bessia C; Cantarella G; Israël A; Wallach D; Courtois G
    Nature; 2003 Aug; 424(6950):801-5. PubMed ID: 12917691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.
    Trompouki E; Hatzivassiliou E; Tsichritzis T; Farmer H; Ashworth A; Mosialos G
    Nature; 2003 Aug; 424(6950):793-6. PubMed ID: 12917689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway.
    Jono H; Lim JH; Chen LF; Xu H; Trompouki E; Pan ZK; Mosialos G; Li JD
    J Biol Chem; 2004 Aug; 279(35):36171-4. PubMed ID: 15226292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the deubiquitinating enzyme CYLD by IkappaB kinase gamma-dependent phosphorylation.
    Reiley W; Zhang M; Wu X; Granger E; Sun SC
    Mol Cell Biol; 2005 May; 25(10):3886-95. PubMed ID: 15870263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
    Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
    Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation of JNK signaling by the tumor suppressor CYLD.
    Reiley W; Zhang M; Sun SC
    J Biol Chem; 2004 Dec; 279(53):55161-7. PubMed ID: 15496400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CYLD, NF-kappaB and NF-kappaB-related factors in salivary gland tumors.
    Fukuda M; Fukuda F; Horiuchi Y; Oku Y; Suzuki S; Kusama K; Sakashita H
    In Vivo; 2006; 20(4):467-72. PubMed ID: 16900776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYLD and the NEMO Zinc Finger Regulate Tumor Necrosis Factor Signaling and Early Embryogenesis.
    Zhao Y; Ma CA; Wu L; Iwai K; Ashwell JD; Oltz EM; Ballard DW; Jain A
    J Biol Chem; 2015 Sep; 290(36):22076-84. PubMed ID: 26224629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].
    Wu CJ; Conze DB; Li T; Srinivasula SM; Ashwell JD
    Nat Cell Biol; 2006 Apr; 8(4):398-406. PubMed ID: 16547522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha.
    Tang ED; Wang CY; Xiong Y; Guan KL
    J Biol Chem; 2003 Sep; 278(39):37297-305. PubMed ID: 12867425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of CYLD might be associated with development of salivary gland tumors.
    Fukuda M; Hiroi M; Suzuki S; Ohmori Y; Sakashita H
    Oncol Rep; 2008 Jun; 19(6):1421-7. PubMed ID: 18497946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.
    Sun SC
    Cell Death Differ; 2010 Jan; 17(1):25-34. PubMed ID: 19373246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF.
    Devin A; Lin Y; Yamaoka S; Li Z; Karin M; Liu Zg
    Mol Cell Biol; 2001 Jun; 21(12):3986-94. PubMed ID: 11359906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin signalling in the NF-kappaB pathway.
    Chen ZJ
    Nat Cell Biol; 2005 Aug; 7(8):758-65. PubMed ID: 16056267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transduction: aspirin, ubiquitin and cancer.
    Wilkinson KD
    Nature; 2003 Aug; 424(6950):738-9. PubMed ID: 12917671
    [No Abstract]   [Full Text] [Related]  

  • 18. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation.
    Roussel RR; Barchowsky A
    Arch Biochem Biophys; 2000 May; 377(1):204-12. PubMed ID: 10775461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGLN3 inhibition of NF-κB is mediated by prolyl hydroxylase-independent inhibition of IκB kinase γ ubiquitination.
    Fu J; Taubman MB
    Mol Cell Biol; 2013 Aug; 33(15):3050-61. PubMed ID: 23732909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus core protein potentiates TNF-alpha-induced NF-kappaB activation through TRAF2-IKKbeta-dependent pathway.
    Chung YM; Park KJ; Choi SY; Hwang SB; Lee SY
    Biochem Biophys Res Commun; 2001 Jun; 284(1):15-9. PubMed ID: 11374864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.